Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

AIDS

Volumn 10, Issue 5, 1996, Pages 493-499

  Bell, Jeanne E ^a,c   Donaldson, Yvonne K ^a   Lowrie, Suzanne ^a   McKenzie, Chris Anne ^a   Elton, Rob A ^a   Chiswick, Ann ^b   Brettle, Raymond P ^b   Ironside, James W ^a   Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Dementia; HIV encephalitis; Homosexuals; Immunocytochemistry; Injecting drug users; Opportunistic infections; Primary lymphoma; Proviral quantification; Zidovudine

Indexed keywords

ANTIGEN P24; ANTIVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; DISEASE COURSE; DRUG ABUSE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCYTOCHEMISTRY; LYMPHOMA; MALE; NEUROPATHOLOGY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS ENCEPHALITIS;

EID: 0029933106     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199605000-00007     Document Type: Article

References (42)

1. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW: Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology 1989, 39:119-122.
2. Price RW, Sidtis JJ, Brew BJ: AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol 1991, 1:155-162.
3. Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991, 1:163-175.
4. McArthur JC, Seines OA, Glass JD, Hoover DR, Bacellar H: HIV dementia: incidence and risk factors. In HIV, AIDS and the Brain. Edited by Price RW, Perry SW. New York: Raven Press; 1994:251-272.
5. Harrison MJG: Neurological complications of HIV infection: clinical aspects. In The Neuropathology of HIV Infection. Edited by Scaravilli F. London: Springer Verlag; 1993:21-33.
6. Price RW: Understanding the AIDS dementia complex (ADC). In HIV, AIDS and the Brain. Edited by Price RW, Perry SW. New York: Raven Press; 1994:1-45.
7. Gehrmann J, Kleihues P: Neuropathology of central nervous system human immunodeficiency virus infection. Curr Diag Pathol 1994, 1:121-130.
8. Petito CK, Cho E-S, Lemann W, Navia BA, Price RW: Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986, 6:636-646.
9. Everall IP, Lantos PL: The neuropathology of HIV: a review of the first 10 years. Int Rev Psych 1991, 3:307-320.
10. Sharer LR: Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 1992, 1:3-11.
11. Budka H, Wiley CA, Kleihues P, et al.: HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991, 1:143-152.
12. Sharer LR, Cho ES, Epstein LG: Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 1985, 16:760.
13. Lantos PL, McLaughlin JE, Scholtz CL, Berry CL: Neuropathology of the brain in HIV infection. Lancet 1989, i:309-311.
14. Esiri MM, Scaravilli F, Millard PR, Harcourt-Webster JN: Neuropathology of HIV infection in haemophiliacs: comparative necropsy study. BMJ 1989, 299:1312-1315.
15. Kleihues P, Leib SL, Strittmatter C, Wiestler OD, Lang W: HIV encephalopathy: incidence, definition and pathogenesis. Results of a Swiss collaborative study. Acta Pathol Japon 1991, 41:197-205.
16. Scaravilli F, Gray F, Mikol J, Sinclair E: Pathology of the nervous system. In The Neuropathology of HIV Infection. Edited by Scaravilli F. London: Springer Verlag; 1993:99-169.
17. Budka H: HIV-related dementia: pathology and possible pathogenesis. In The Neuropathology of HIV Infection. Edited by Scaravilli F, London: Springer Verlag; 1993:171-185.
18. Navia BA, Jordan BD, Price RW: The AIDS dementia complex: clinical features. Ann Neurol 1986, 19:517-524.
19. Berger JR, Kaszovitz B, Post MJD, Dickinson G: Progressive multifocal leucoencephalopathy associated with human immunodeficiency virus infection. Clin Rev 1987, 107:78-87.
20. Chiodi F, Fenyö EM: Neurotropism of human immunodeficiency virus. Brain Pathol 1991, 1:185-191.
21. Davis LE, Hjelle BL, Miller VE, et al.: Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992, 42:1736-1739.
22. Bell JE, Busuttil A, Ironside JW, et al.: Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 1993, 168:818-824.
23. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen ISY: High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990, 343:85-89.
24. Boni J, Emmerich BS, Leib SL, Wiestler MD, Schupbach J, Kleihues P: PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 1993, 43:1813-1817.
25. Achim CL, Wang R, Miners DK, Wiley CA: Brain viral burden in HIV infection. J Neuropathol Exp Neurol 1994, 53:284-294.
26. Nelson JA, Reynolds-Kohler C, Oldstone MBA, Wiley CA: HIV and HCMV coinfect brain cells in patients with AIDS. Virology 1988, 165:286-290.
27. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993, 57:183-289.
28. Gray F, Bélec L, Keohane C, et al.: Zidovudine therapy and HIV encephalitis: a 10-year neuropathological study. AIDS 1994, 8:489-493.
29. Portegies P, Enting RH, de Gans J, et al.: Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS 1993, 7:669-675.
30. Burns S, Brettle RP, Gore SM, Peutherer J, Robertson JR: Epidemiology of injection drug use related HIV in Edinburgh: a historical perspective and new insight on past HIV incidence from the retrospective HIV testing of stored sera. J Infect 1996, 32:53-62.
31. Centers for Disease Control: Revision of CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36:3S-14S.
32. Egan V, Brettle RP, Goodwin GM: The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease. Br J Psychiatry 1992, 161:522-531.
33. Goodwin GM, Chiswick A, Egan VG, St Clair D, Brettle RP: The Edinburgh cohort of HIV-positive drug users: auditory event related potentials shows slowing in patients with CDC stage IV disease. AIDS 1990, 4:1243-1250.
34. Goodin DS, Aminoff MJ: Electrophysiology differences between subtypes of dementia. Brain 1986, 109:1103-1113.
35. Donaldson YK, Bell JE, Holmes EC, Hughes ES, Brown HK, Simmonds P: In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in theV3 loop. J Virol 1994, 68:5991-6005.
36. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Leigh Brown AJ: Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990, 64:864-872.
37. Donaldson YK, Bell JE, Ironside JW, et al.: Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 1994, 343:382-343.
38. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992, 323:321-329.
39. Gosztonyi G, Artigas J, Lamperth L, Webster HD: Human immunodeficiency virus (HIV) distribution in HIV encephalitis: study of 19 cases with combined use of in situ hybridisation and immunocytochemistry. J Neuropathol Exp Neurol 1994, 53:521-534.
40. Budka H, Costanzi G, Cristina S, et al.: Brain pathology induced by infection with the human immunodeficiency virus (HIV). Acta Neuropathol 1987, 75:185-198.
41. Eskild A, Magnus P, Sohlberg C, et al.: Slow progression to AIDS in intravenous drug users infected with HIV in Norway. J Epidemiol Community Health 1994, 48:383-387.
42. Sinclair E, Gray F, Scaravilli F: PCR detection of HIV proviral DNA in the brain of an asymptomatic HIV-positive patient. J Neurol 1992, 239:469-470.